The Role of NSAIDs in Colorectal Cancer Treatment
Author Information
Author(s): Ricchi P, Zarrilli R, di Palma A, Acquaviva A M
Primary Institution: Dipartimento di Biologia e Patologia Cellulare e Molecolare ‘L. Califano’, Istituto di Endocrinologia ed Oncologia Sperimentale ‘G. Salvatore’ del Consiglio Nazionale delle Ricerche, Facoltà di Medicina e Chirurgia, Università ‘Federico II’, Napoli, Italy
Hypothesis
Can nonsteroidal anti-inflammatory drugs (NSAIDs) prevent or treat colorectal cancer?
Conclusion
NSAIDs, particularly COX-2 inhibitors, may play a significant role in preventing and treating colorectal cancer by inducing apoptosis and reducing tumor growth.
Supporting Evidence
- Epidemiological studies suggest that NSAIDs can hinder the development of colon cancer.
- COX-2 expression is increased in colorectal cancer, indicating its role in carcinogenesis.
- NSAIDs have been shown to induce apoptosis in colon cancer cells in vitro.
Takeaway
This study suggests that certain pain-relief medications can help stop cancer from growing and make cancer cells die.
Methodology
The review discusses various studies on the effects of NSAIDs on colorectal cancer cells, focusing on their ability to induce apoptosis and inhibit tumor growth.
Limitations
The review highlights the need for more clinical trials to confirm the effectiveness of NSAIDs in cancer treatment.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website